Second, a study from a group in Hong Kong reported a 2-step approach using CK18 fragments and fibroblast growth factor 21 (FGF21) further improved the accuracy in diagnosing NASH. This evidence concerns the gene KRT18 and metabolic dysfunction-associated steatohepatitis.